SWOG clinical trial number
SWOG-9242

Evaluation of Taxotere in Small Cell Lung Carcinoma, Phase II

Closed
Phase
Accrual
94%
Published
Abbreviated Title
Evaluation of Taxotere in Small Cell Lung Carcinoma, Phase II
Activated
05/01/1993
Closed
01/15/1997

Research committees

Lung Cancer

Publication Information Expand/Collapse

1999

Evaluation of docetaxel in previously untreated extensive stage small cell lung cancer: A Southwest Oncology Group phase II trial.

PJ Hesketh;JJ Crowley;HA Burris;SK Williamson;SP Balcerzak;DM Peereboom;JW Goodwin;HM Gross;DF Moore;RB Livingston;DR Gandara Cancer Journal from Scientific American 5(4):237-241

1998

Docetaxel (taxotere) in extensive stage small cell lung cancer (SCLC): A phase II trial of the Southwest Oncology Group (SWOG).

HA Burris;JJ Crowley;SK Williamson;DR Gandara;RB Livingston Proc of the American Society of Clinical Oncology 17:451a(#1737)

Other Clinical Trials

SWOG Clinical Trial Number
S2302

PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER
Research Committee(s)
Lung Cancer
Activated
03/06/2023
Accrual
95%
Open
Phase
SWOG Clinical Trial Number
A082002

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open